Skip to content

ASBP

Aspire Biopharma Holdings, Inc.

NASDAQ · Healthcare · Biotechnology · US

$8.54
−6.36%
Ask drillr

Latest reported

Last report date
Aug 13, 2026
EPS actual
-$1.00
EPS estimate
Revenue actual
$63.1K
Revenue estimate

Track record

Trailing twelve quarters

EPS beats (12Q)
EPS misses (12Q)
EPS in line (12Q)
Avg surprise (4Q)
Revenue beats (12Q)
Earnings call history

No earnings call summaries available

Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Aug 13, 2026-$1.00$63.1K
May 15, 2026-$21$28.4K
Mar 30, 2026-$16$4.3K
Nov 14, 2025-$1.60$1.9K
Aug 13, 2025-$0.04
May 14, 2025-$0.42
Nov 14, 2024-$0.02
Aug 16, 2024-$0.02
Jun 5, 2024-$0.07
Mar 11, 2024-$0.00
May 11, 2023$0.02
Mar 21, 2023$0.02

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Aug 13, 2026